| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | -0.0096 | 0.8 |
| mRNA | HLI 373 | CTRPv2 | pan-cancer | AAC | -0.0093 | 0.8 |
| mRNA | AC55649 | CTRPv2 | pan-cancer | AAC | -0.0099 | 0.8 |
| mRNA | PDMP | CTRPv2 | pan-cancer | AAC | 0.0097 | 0.8 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | -0.014 | 0.8 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | ML334 diastereomer | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | -0.013 | 0.8 |
| mRNA | BRD-A86708339 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | -0.074 | 0.8 |